STOCKHOLM, Nov. 3, 2026 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) today announced that the United States Patent and Trademark Office (USPTO) has granted a patent relating to an improved dosing regimen for MOB-015, the company's topical drug for onychomycosis. The U.S. is the first...
Hence then, the article about moberg pharma granted u s patent relating to improved dosing of mob 015 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Moberg Pharma granted U.S. patent relating to improved dosing of MOB-015 )
Also on site :
- Dolly Parton donated $1 million to Vanderbilt University Medical Center in 2020 to help fund the critical early research behind Moderna’s COVID-19 vaccine
- In 1984, Alabama Released the Wrong Song as a Single; Radio DJs Flipped the Record Over and Made the B-Side Their 14th Straight No. 1
- Walmart Will Have Three Major Shopping Events This Holiday Season